Molecular Partners (MOLN) said Tuesday it plans to reduce its workforce by up to 24%, or up to 40 positions.
The company said it expects its cash runway to extend into 2028, beyond its previous outlook of 2027, as a result of the job cuts.
Molecular Partners expects the full implementation of the changes to be enacted by the end of this year and the cost reduction to become fully effective in early 2026.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。